COMBATTING URGENT VIRAL DISEASE THREATS Dual Approach to Advance Galidesivir as a Pan - Filovirus Medical Countermeasure BioShares 2026 Dr David Foster, CEO & Managing Director August 7, 2026 ASX: ILA Cumulative Ebola cases in past outbreaks 01 Island Pharmaceuticals Limited Days since...
Investor presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
In the deck
Earlier from Island Pharmaceuticals
- Quarterly Appendix 4C and Activities Report
- Texas Biomed SOW accelerates pivotal FDA pathway
- Investor Presentation - Ebola Clinical Program
- Galidesivir approved for treatment use in in Ebola epidemic
- Pause in Trading
Later from Island Pharmaceuticals
- Application for quotation of securities - ILA
- Cleansing Notice
- Date of AGM & Closing Date for Director Nominations
- Island boosts Galidesivir supply as Ebola surges
- Preliminary Final Report
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals